Illumina's BaseSpace Variant Interpreter encompasses standards for analysis and interpretation developed under a partnership between the firm and Genomics England.
Congenica will use the proceeds to establish its presence in the US and China, where it will court not only clinical genetics labs, but specialists, academics, biotech, and pharma.
The company will use the proceeds from the round to invest in sales and marketing efforts for its Sapientia clinical genome analysis platform, as well as for R&D.
Genomics England will use the product to aid scientists and clinicians in 13 National Health Service Genomic Medical Centres with clinical reporting and interpretation.
The center, which is seen as a bellwether for integrating genomic information with EMRs, will use the data to inform efforts to prevent chronic, common diseases.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
